文献速递急性肾损伤

社区处方抗生素与急性肾损伤风险:自身对照病例系列研究

Risk of acute kidney injury following community prescription of antibiotics: self-controlled case series.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

该研究在苏格兰Tayside地区纳入2004至2012年间≥18岁且测过血肌酐的社区人群,采用自身对照病例系列法评估口服抗生素与AKI风险。结果显示,2008至2012年AKI发生率上升16%,磺胺类/甲氧苄啶/呋喃妥因使用上升47%;任何抗生素使用与AKI风险轻度升高相关(IRR 1.16),磺胺类或甲氧苄啶风险最高(IRR 3.07),氟喹诺酮类和呋喃妥因未见显著升高。

要点

  • 社区抗生素使用与AKI风险相关,磺胺类或甲氧苄啶风险最高(IRR 3.07)。
  • 氟喹诺酮类和呋喃妥因未显示显著增加AKI风险。
  • 2008至2012年社区AKI发生率上升16%,同期相关抗生素使用上升47%。

核心结论

  • 社区使用磺胺类或甲氧苄啶与AKI风险显著增加相关,而氟喹诺酮类和呋喃妥因未显示显著关联。
  • 2008至2012年间社区AKI发生率上升16%,同期磺胺类、甲氧苄啶和呋喃妥因使用上升47%。

研究设计与样本

  • 自身对照病例系列研究,纳入苏格兰Tayside地区2004年1月1日至2012年12月31日期间≥18岁且测过血肌酐的所有个体。
  • AKI定义采用KDIGO标准,收集口服社区处方抗生素数据,计算抗生素暴露期与非暴露期AKI的发病率比(IRR)。

主要发现

  • 研究期间12 777人发生14 900次社区获得性AKI,其中68%为AKI 1期,16%为2期,16%为3期。
  • 任何抗生素使用期间AKI的IRR为1.16(95%CI 1.10-1.23)。
  • 磺胺类或甲氧苄啶使用期间AKI的IRR为3.07(95%CI 2.81-3.35)。
  • 氟喹诺酮类使用期间AKI的IRR为1.13(95%CI 0.94-1.35),呋喃妥因使用期间IRR为1.16(95%CI 0.91-1.50)。

临床怎么用

  • 社区处方磺胺类或甲氧苄啶时应关注AKI风险,尤其对高危患者。
  • 使用氟喹诺酮类或呋喃妥因时,AKI风险未见显著增加,但仍需结合患者情况评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Development of acute kidney injury (AKI) following the use of antibiotics such as sulphonamides, trimethoprim and aminoglycosides is a frequently described phenomenon. More recently, an association between fluoroquinolone use and AKI has been suggested. The aim of this study was to evaluate the risk of AKI as an unintended consequence of commonly prescribed antibiotics in a large community cohort using a method that fully adjusts for underlying patient characteristics, including potential unmeasured confounders. METHODS: A self-controlled case study was conducted and included all individuals aged 18 years and over in the Tayside region of Scotland who had a serum creatinine measured between 1 January 2004 and 31 December 2012. AKI episodes were defined using the Kidney Disease: Improving Global Outcomes definition. Data on oral community-prescribed antibiotics (penicillins, cephalosporins, fluoroquinolones, sulphonamides and trimethoprim, macrolides and nitrofurantoin) were collected for all individuals. Incidence rate ratios (IRRs) for AKI associated with antibiotic exposure versus time periods without antibiotic exposure were calculated. RESULTS: Combined use of sulphonamides, trimethoprim and nitrofurantoin rose by 47% and incidence of community-acquired AKI rose by 16% between 2008 and 2012. During the study period 12 777 individuals developed 14 900 episodes of AKI in the community, of which 68% was AKI Stage 1, 16% Stage 2 and 16% Stage 3. The IRR of AKI during any antibiotic use was 1.16 [95% confidence interval (CI) 1.10-1.23], and this was highest during sulphonamides or trimethoprim use; IRR 3.07 (95% CI 2.81-3.35). Fluoroquinolone and nitrofurantoin use was not associated with a significantly increased rate of AKI; IRR 1.13 (95% CI 0.94-1.35) and 1.16 (95% CI 0.91-1.50), respectively. CONCLUSIONS: Incidence of AKI rose by 16% between 2008 and 2012. In the same period the use of sulphonamides, trimethoprim and nitrofurantoin increased by 47%. A significant increased risk of AKI was seen with the use of sulphonamides and trimethoprim, but not with fluoroquinolones or nitrofurantoin.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Rennie TJW, De Souza N, Donnan PT, et al. Risk of acute kidney injury following community prescription of antibiotics: self-controlled case series. Nephrol Dial Transplant. 2019. PMID: 29961876. doi:10.1093/ndt/gfy187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。